USANA Health Sciences, Inc. (NYSE:USNA) Insider David Mulham Mulham Sells 3,515 Shares

Key Points

• Insider Selling: USANA Health Sciences insider David Mulham sold 3,515 shares at an average price of $30.26, totaling over $106,000, which represents a 27.51% decrease in their ownership position.
• Strong Earnings: For the quarter ending July 22, USANA reported an EPS of $0.74, exceeding expectations of $0.54, with revenues of $235.85 million surpassing the anticipated $225.20 million.
• Analyst Upgrade: Wall Street Zen has upgraded USANA Health Sciences from a "hold" to a "buy" rating, reflecting positive sentiment among analysts regarding the company's future performance.

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) insider David Mulham Mulham sold 3,515 shares of the firm's stock in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total transaction of $106,363.90. Following the completion of the transaction, the insider owned 9,260 shares in the company, valued at approximately $280,207.60. The trade was a 27.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

USANA Health Sciences Trading Up 1.0%

NYSE:USNA traded up $0.30 during mid-day trading on Monday, hitting $29.16. The stock had a trading volume of 7,067 shares, compared to its average volume of 183,061. The stock has a market capitalization of $543.07 million, a price-to-earnings ratio of 16.25, a P/E/G ratio of 0.92 and a beta of 0.61. The company has a 50 day simple moving average of $30.90 and a 200-day simple moving average of $29.88. USANA Health Sciences, Inc. has a 52 week low of $23.10 and a 52 week high of $41.83.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.20. The firm had revenue of $235.85 million for the quarter, compared to the consensus estimate of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. As a group, equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

Institutional Trading of USANA Health Sciences

Hedge funds have recently bought and sold shares of the company. Teacher Retirement System of Texas acquired a new position in shares of USANA Health Sciences in the 1st quarter worth approximately $888,000. GAMMA Investing LLC grew its stake in shares of USANA Health Sciences by 49,082.4% in the 1st quarter. GAMMA Investing LLC now owns 8,361 shares of the company's stock worth $225,000 after purchasing an additional 8,344 shares during the last quarter. Millennium Management LLC acquired a new position in shares of USANA Health Sciences in the 4th quarter worth approximately $633,000. Exchange Traded Concepts LLC grew its stake in shares of USANA Health Sciences by 7.1% in the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock worth $248,000 after purchasing an additional 606 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of USANA Health Sciences by 7.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock worth $27,751,000 after purchasing an additional 55,059 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.